SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-249162
Filing Date
2021-08-17
Accepted
2021-08-17 16:21:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d136068ddefa14a.htm DEFA14A 15209
2 GRAPHIC g136068g01a11.jpg GRAPHIC 269455
  Complete submission text file 0001193125-21-249162.txt   387776
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-36830 | Film No.: 211183035
SIC: 2834 Pharmaceutical Preparations